Prasol Chemicals Earnings Call Transcript: Key Takeaways
Record Q2 revenue ₹413 Cr (+38.6%), EBITDA ₹58 Cr (+86.1%), PAT ₹38 Cr (+122.2%); Q1 ₹25 Cr inventory gain flatters H1; FY27 guidance reiterated.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Record Q2 revenue ₹413 Cr (+38.6%), EBITDA ₹58 Cr (+86.1%), PAT ₹38 Cr (+122.2%); Q1 ₹25 Cr inventory gain flatters H1; FY27 guidance reiterated.
Q2 FY27 revenue Rs412.6cr (+38.6% YoY), PAT Rs37.9cr (+122.2%), EBITDA margin 14.0%. H1 FY27 revenue Rs846.2cr (+37.1%), highest-ever Q2.
Prasol Chemicals reported record Q1 FY27 performance with revenue up 36% YoY. Strategy focuses on expanding high-margin acetone and phosphorus derivatives via massive capex and R&D.
Prasol Chemicals reported record Q1FY27 performance following its Sep 2026 IPO, driven by volume growth and improved product mix in Acetone and Phosphorus derivatives.